Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Operating Expenses: 2019-2025

Historic Operating Expenses for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to $114.3 million.

  • Harmony Biosciences Holdings' Operating Expenses rose 40.18% to $114.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $416.1 million, marking a year-over-year increase of 15.25%. This contributed to the annual value of $367.1 million for FY2024, which is 36.59% up from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Operating Expenses is $114.3 million, which was up 0.14% from $114.2 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year Operating Expenses high stood at $119.3 million for Q2 2024, and its period low was $34.7 million during Q1 2021.
  • For the 3-year period, Harmony Biosciences Holdings' Operating Expenses averaged around $87.3 million, with its median value being $85.1 million (2023).
  • Its Operating Expenses has fluctuated over the past 5 years, first decreased by 22.93% in 2023, then surged by 91.50% in 2024.
  • Harmony Biosciences Holdings' Operating Expenses (Quarterly) stood at $44.8 million in 2021, then climbed by 20.21% to $53.8 million in 2022, then spiked by 58.08% to $85.1 million in 2023, then rose by 7.13% to $91.1 million in 2024, then skyrocketed by 40.18% to $114.3 million in 2025.
  • Its Operating Expenses was $114.3 million in Q3 2025, compared to $114.2 million in Q2 2025 and $96.5 million in Q1 2025.